2018-574-E Emergency Svc - South Orange Rescue Squad operational agreement

Browse Search

267 Occupational Safety and Health Admin., Labor §1910.1030 such events as needlesticks, human bites, cuts, and abrasions. Personal Protective Equipment is spe- cialized clothing or equipment worn by an employee for protection against a hazard. General work clothes (e.g., uni- forms, pants, shirts or blouses) not in- tended to function as protection against a hazard are not considered to be personal protective equipment. Production Facility means a facility engaged in industrial-scale, large-vol- ume or high concentration production of HIV or HBV. Regulated Waste means liquid or semi-liquid blood or other potentially infectious materials; contaminated items that would release blood or other potentially infectious materials in a liquid or semi-liquid state if com- pressed; items that are caked with dried blood or other potentially infec- tious materials and are capable of re- leasing these materials during han- dling; contaminated sharps; and patho- logical and microbiological wastes con- taining blood or other potentially in- fectious materials. Research Laboratory means a labora- tory producing or using research-lab- oratory-scale amounts of HIV or HBV. Research laboratories may produce high concentrations of HIV or HBV but not in the volume found in production facilities. Sharps with engineered sharps injury protections means a nonneedle sharp or a needle device used for withdrawing body fluids, accessing a vein or artery, or administering medications or other fluids, with a built-in safety feature or mechanism that effectively reduces the risk of an exposure incident. Source Individual means any indi- vidual, living or dead, whose blood or other potentially infectious materials may be a source of occupational expo- sure to the employee. Examples in- clude, but are not limited to, hospital and clinic patients; clients in institu- tions for the developmentally disabled; trauma victims; clients of drug and al- cohol treatment facilities; residents of hospices and nursing homes; human re- mains; and individuals who donate or sell blood or blood components. Sterilize means the use of a physical or chemical procedure to destroy all microbial life including highly resist- ant bacterial endospores. Universal Precautions is an approach to infection control. According to the concept of Universal Precautions, all human blood and certain human body fluids are treated as if known to be in- fectious for HIV, HBV, and other bloodborne pathogens. Work Practice Controls means controls that reduce the likelihood of exposure by altering the manner in which a task is performed (e.g., prohibiting recap- ping of needles by a two-handed tech- nique). (c) Exposure control—(1) Exposure Con- trol Plan. (i) Each employer having an employee(s) with occupational expo- sure as defined by paragraph (b) of this section shall establish a written Expo- sure Control Plan designed to elimi- nate or minimize employee exposure. (ii) The Exposure Control Plan shall contain at least the following ele- ments: (A) The exposure determination re- quired by paragraph (c)(2), (B) The schedule and method of im- plementation for paragraphs (d) Meth- ods of Compliance, (e) HIV and HBV Research Laboratories and Production Facilities, (f) Hepatitis B Vaccination and Post-Exposure Evaluation and Fol- low-up, (g) Communication of Hazards to Employees, and (h) Recordkeeping, of this standard, and (C) The procedure for the evaluation of circumstances surrounding exposure incidents as required by paragraph (f)(3)(i) of this standard. (iii) Each employer shall ensure that a copy of the Exposure Control Plan is accessible to employees in accordance with 29 CFR 1910.20(e). (iv) The Exposure Control Plan shall be reviewed and updated at least annu- ally and whenever necessary to reflect new or modified tasks and procedures which affect occupational exposure and to reflect new or revised employee po- sitions with occupational exposure. The review and update of such plans shall also: (A) Reflect changes in technology that eliminate or reduce exposure to bloodborne pathogens; and (B) Document annually consideration and implementation of appropriate commercially available and effective VerDate Mar<15>2010 09:17 Aug 04, 2010Jkt 220114PO 00000Frm 00277Fmt 8010Sfmt 8010Q:\29\29V6.TXTofr150PsN: PC150 DocuSign Envelope ID: 79C5D167-B6CA-4E59-B4AC-AA38CC1B20BD